IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)
India · Delayed Price · Currency is INR 207.48
+4.53 (2.23%)
Nov 11, 2026, 1:15 PM IST
NSE:IOLCP Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 27,511 | 23,191 | 20,792 | 21,328 | 22,171 | 21,840 |
Revenue Growth | 26.76% | 11.54% | -2.51% | -3.80% | 1.52% | 11.03% |
Gross Profit Gross Profit Growth | 9,874 | 8,023 | 6,621 | 7,143 | 6,566 | 6,028 |
Operating Income Operating Income Growth | 2,794 | 1,895 | 1,305 | 1,677 | 1,801 | 2,161 |
Net Income Net Income Growth | 2,032 | 1,376 | 1,011 | 1,344 | 1,391 | 1,677 |
Earnings Per Share EPS Growth | 6.92 | 4.69 | 3.44 | 4.58 | 4.74 | 5.71 |
EPS Growth | 75.11% | 36.31% | -24.89% | -3.38% | -17.02% | -62.52% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Pharmaceutical Pharmaceutical Growth | 16,728 | 13,963 | 12,123 | 12,625 | 12,585 | 10,027 |
Chemical Chemical Growth | 13,537 | 11,605 | 10,794 | 11,402 | 11,949 | 13,183 |
Unallocated Unallocated Growth | 208.3 | 213.8 | 224.3 | 58 | 48.7 | 64.9 |
Inter Segment Inter Segment Growth | -2,754 | -2,377 | -2,125 | -2,758 | -2,411 | -1,434 |
Total Total Growth | 27,720 | 23,404 | 21,016 | 21,328 | 22,171 | 21,840 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1,301 | 2,003 | 2,093 | 1,428 | 186.4 | 1,197 |
Total Debt Total Debt Growth | 2,013 | 1,354 | 1,170 | 327.6 | 798.1 | 439.5 |
Net Cash (Debt) Net Cash Growth | -711.4 | 648.8 | 922.5 | 1,100 | -611.7 | 757.8 |
Net Cash Growth | - | -29.67% | -16.14% | - | - | -77.30% |
Net Cash Per Share Net Cash Per Share Growth | -2.42 | 2.21 | 3.14 | 3.75 | -2.08 | 2.58 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,116 | 2,143 | 1,786 | 2,898 | 1,223 | 930.5 |
Capital Expenditures CapEx Growth | -2,497 | -1,730 | -2,136 | -2,742 | -2,118 | -1,533 |
Free Cash Flow Free Cash Flow Growth | -381.3 | 413.3 | -349.3 | 156.1 | -895.5 | -602.4 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 35.89% | 34.59% | 31.84% | 33.49% | 29.61% | 27.60% |
Operating Margin | 10.16% | 8.17% | 6.28% | 7.86% | 8.12% | 9.90% |
Pretax Margin | 9.90% | 7.95% | 6.64% | 8.52% | 8.51% | 10.30% |
Profit Margin | 7.39% | 5.93% | 4.86% | 6.30% | 6.28% | 7.68% |
FCF Margin | -1.39% | 1.78% | -1.68% | 0.73% | -4.04% | -2.76% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | 0.800 | 1.000 | 0.800 | 0.800 |
Dividend Per Share Growth | 25.00% | 25.00% | -20.00% | 25.00% | 0% | -33.33% |
Dividend Yield | 0.48% | 1.38% | 1.31% | 1.38% | 1.41% | 1.13% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 29.99 | 15.51 | 17.77 | 15.79 | 11.94 | 12.39 |
P/FCF Ratio | - | 51.67 | - | 135.95 | - | - |
PS Ratio | 2.16 | 0.92 | 0.86 | 1.00 | 0.75 | 0.95 |